scispace - formally typeset
S

Steve Ryder

Researcher at York University

Publications -  8
Citations -  2188

Steve Ryder is an academic researcher from York University. The author has contributed to research in topics: Internal medicine & Population. The author has an hindex of 5, co-authored 5 publications receiving 1641 citations.

Papers
More filters
Journal ArticleDOI

Cannabinoids for Medical Use: A Systematic Review and Meta-analysis.

TL;DR: There was moderate- quality evidence to support the use of cannabinoids for the treatment of chronic pain and spasticity and low-quality evidence suggesting that cannabinoids were associated with improvements in nausea and vomiting due to chemotherapy, weight gain in HIV infection, sleep disorders, and Tourette syndrome.
Journal ArticleDOI

The burden, epidemiology, costs and treatment for Duchenne muscular dystrophy : an evidence review

TL;DR: This first systematic review of treatment, progression, severity and quality of life in Duchenne Muscular Dystrophy provides the most recent description of the burden, epidemiology, illness costs and treatment patterns in DMD.
Journal ArticleDOI

A systematic review of the international prevalence of BRCA mutation in breast cancer

TL;DR: Poor reporting of gBRCA status and basis of selection implies a need for further large well-reported BRCA mutation prevalence studies in breast cancer.
Journal ArticleDOI

Ivacaftor for the treatment of patients with cystic fibrosis and the G551D mutation: a systematic review and cost-effectiveness analysis

TL;DR: The available evidence suggests that ivacaftor is a clinically effective treatment for patients with CF and the G551D mutation; the high cost of ivACaftor may prove an obstacle in the uptake of this treatment.
Journal ArticleDOI

SeHCAT [tauroselcholic (selenium-75) acid] for the investigation of bile acid malabsorption and measurement of bile acid pool loss: a systematic review and cost-effectiveness analysis.

TL;DR: A systematic review was conducted to summarise the evidence on the clinical effectiveness of Se HCAT for the assessment of BAM and the measurement of bile acid pool loss and found three studies assessing the relationship between the SeHCAT test and response to treatment with cholestyramine.